Navigation Links
AlphaBio Centrix, LLC Announces a New Discovery for Programming Energetic Patches
Date:3/30/2012

LAS VEGAS, March 30, 2012 /PRNewswire/ -- AlphaBio Centrix, a Nevada-based biotech corporation, announced this week its development of a new bio-programming process – Infusion Technology. This is a term used in programming wearable TheraEX(TM) skin patches that can influence the human auric field, the energy field that surrounds all life forms.

When fully functional, this energy field is far reaching. In fact, in its basic form, it embodies seven major layers powered through seven major energy centers called Chakras.

"We are excited to share that we have discovered a way to use this auric field to influence specific bio-triggers which vibrate at a designated combination of frequencies," explains Richard Eaton, president, AlphaBio Centrix.

These frequencies communicate with, and enhance the body's natural energetic system. By wearing the TheraEX "Bio App" 24 hours a day for the duration of the protocol, the body is immersed in a corrective, informational and energetic exchange that promotes the balance of weak, disturbed and overactive energy.

AlphaBio Centrix uses a special substrate material for TheraEX ("Therapeutic Experience") that is sensitive to radio frequencies and is bonded to a non-latex woven medical pad manufactured by 3M Company. It's been formulated with an adhesive made for different types of skin conditions. This substrate material is then transformed by Infusion Technology, adding digital information onto the material.

These Bio Apps are an ideal alternative health care solution, and according to its recent research studies, mounting stress problems are causing an overwhelming effect on people's health and emotional problems. Stress factors include: today's uncertain work environment; and increasing workloads which may result in work-related injuries and health problems.

For more information on T
'/>"/>

SOURCE AlphaBio Centrix, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/z54c4k/biomedical ) ... Refrigerators and Freezers Market - Global Industry Analysis, ... 2022" report to their offering. ... has been segmented based on applications: hospitals, research ... The others segment includes applications of biomedical refrigerators ...
(Date:7/28/2015)... July 28, 2015 Deerfield Management Company, L.P. ... Fund, L.P., which will invest in groundbreaking advancements in ... diseases, cancer, and orphan diseases. The venture capital fund ... therapeutics are developed and improve the way healthcare is ... the largest healthcare-focused venture funds in the sector, will ...
(Date:7/28/2015)... DIEGO , July 28, 2015  Kerastem Technologies ... approval from the U.S. FDA Center For Biologics Evaluation ... Therapies to conduct a clinical trial investigating the safety ... of female and early male pattern baldness (androgenic alopecia). ... STYLE trial, follows initial clinical work in ...
(Date:7/28/2015)... BEACH, Calif. , July 28, 2015 /PRNewswire-USNewswire/ ... announced that it has hit a milestone of ... Signafuse was FDA 510(k) cleared in early 2014 ... use in posterolateral spine fusion procedures.  This is ... products, as less than 6% of new synthetic ...
Breaking Biology Technology:Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2Revolutionary Bone Graft Exceeds Expectations 2
... chain technology solutions provider, today announced the opening of ... staff of twenty, the office will grow to sixty ... responsible for sales, customer support and product development for ... industry to establish Asia-Pacific headquarters in China. , ...
... Street Journal featured the news of pharmaceutical giant ... for $1.3 billion. , ,Esperion, which is based ... be useful for the treatment of the heart disease ... with drugs like Lipitor for high cholesterol ($8 billion ...
... , a start-up formed by two UW-Madison students, was acquired ... cash. The Sioux Falls, S.D.-based Raven is a manufacturing company, ... ammonia for farmers, is expected to complement Ravens existing line ... for us at Fluent as it marks the culmination of ...
Cached Biology Technology:Holiday Gift From Big Pharma 2
(Date:7/8/2015)... -- The consumer products industry for innovative tech ... such as wearables, smart wallets & other smart technology are ... continues to rapidly grow.  Biometrics & Wearable Device Companies in ... Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: AAPL ... GPRO ) and Baidu Inc. (NASDAQ: BIDU ) ...
(Date:7/2/2015)... , June 25, 2015 ... announced the addition of the "Natural Language ... Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) ... their offering. The key vendors occupying ... HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS ...
(Date:6/30/2015)... Genisphere announced Tom Bliss ... further develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss ... much of the last 25 years in leadership positions ... Johnson & Johnson. Tom started his career in Investment ... Finance. He graduated from Dartmouth College with a BA ...
Breaking Biology News(10 mins):Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... 2013  Pfenex Inc. today announced that the Department of ... Research and Development Authority (BARDA), has modified its prime ... existing Pfenex contractual relationship begun in July, 2010. This ... support the development of a next generation rPA-based anthrax ...
... Resveratrol, a naturally occurring polyphenol compound produced by the ... red wine, has been touted as a beneficial supplement ... been supported by some experimental studies, whereas others suggest ... multiple sclerosis (MS) models published in The American ...
... Sept. 30, 2013 /PRNewswire-iReach/ -- Clinilabs, a contract research ... services to industry, announced today that they have begun ... medication for Type 2 Diabetes Mellitus.  The study is ... multiple daily doses of the investigational medication over periods ...
Cached Biology News:Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract and Increase Funding for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine 2Resveratrol, found in red wine, worsens MS-like symptoms and neuropathology in mice 2Resveratrol, found in red wine, worsens MS-like symptoms and neuropathology in mice 3Leading Pharma Company Selects Clinilabs to Conduct a Phase 1 Study of an Investigational Type 2 Diabetes Medication 2
... RNase H degrades, as an endoribonuclease, ... DNA hybrids of natural origin, e.g. ... synthetic complexes, e.g. poly(A) x poly(dT). ... and 3-OH termini. Nearly no activity ...
Unit Definition: 1 U corresponds to the amount of enzyme which produces 1 mol protons per minute at pH 5.5 and 30C (peptin from citrus peel, Fluka-No. 76280, as substrate)...
Recorder, 6", 7 Day, 1 Pen, 0 to 100°C, 220V, 50/60 Hz, for 4520, Customer Installed...
... detection systems provide linking and labelling ... species specific primary antibodies for visualising ... is accomplished using an ultra-sensitive indirect ... labelling technology. Secondary antibodies are polymerised ...
Biology Products: